Clinical Trial Update: OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating OH2 oncolytic viral therapy for non-muscle-invasive bladder cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• OH2 Oncolytic Viral Therapy

Snippet

Sponsor: Binhui Biopharmaceutical Co., Ltd. | Conditions: Non-muscle-invasive Bladder Cancer | Phase 1, Phase 2 | Status: RECRUITING